Influenza virus vaccine intranasal (Acambis/Evans Vaccines)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameInfluenza virus vaccine intranasal (Acambis/Evans Vaccines)
Drug Alias NameN/A
ClassificationVaccines > Biological material > Viral vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAcambisEvans Vaccines Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAcambisEvans Vaccines Ltd
Active IndicationsN/A
Inactive IndicationsInfluenza, Human

Other Information

ATC CodeN/A
Related LinksN/A